J. Goldman & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Buy |
+1,045
| New | +$465K | 0.01% | 275 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 493 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 492 |
|
|
2024
Q2 | – | Sell |
-4,236
| Closed | -$1.77M | – | 464 |
|
|
2024
Q1 | $1.77M | Buy |
+4,236
| New | +$1.77M | 0.06% | 159 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 355 |
|
|
2023
Q3 | – | Sell |
-1,750
| Closed | -$616K | – | 366 |
|
|
2023
Q2 | $616K | Buy |
+1,750
| New | +$616K | 0.02% | 180 |
|
|
2023
Q1 | – | Sell |
-30,168
| Closed | -$8.71M | – | 386 |
|
|
2022
Q4 | $8.71M | Buy |
+30,168
| New | +$8.71M | 0.43% | 52 |
|
|
2022
Q2 | – | Sell |
-11,970
| Closed | -$3.12M | – | 363 |
|
|
2022
Q1 | $3.12M | Buy |
11,970
+6,708
| +127% | +$1.75M | 0.14% | 113 |
|
|
2021
Q4 | $1.16M | Buy |
+5,262
| New | +$1.16M | 0.06% | 188 |
|
|
2021
Q2 | – | Sell |
-29,508
| Closed | -$6.34M | – | 423 |
|
|
2021
Q1 | $6.34M | Buy |
+29,508
| New | +$6.34M | 0.2% | 81 |
|
|
2017
Q3 | – | Sell |
-23,500
| Closed | -$3.03M | – | 292 |
|
|
2017
Q2 | $3.03M | Buy |
+23,500
| New | +$3.03M | 0.16% | 82 |
|